scholarly journals Corrigendum to: Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population–based case–control study. Eur J Intern Med. 2019 Jan;59:65-69

2021 ◽  
Author(s):  
Henrik Falhammar ◽  
Jonatan D. Lindh ◽  
Jan Calissendorff ◽  
Jakob Skov ◽  
David Nathanson ◽  
...  
Keyword(s):  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Control Study

Proton pump inhibitors increase the risk of cholecystitis: a population-based case–control study

Gut ◽  
2018 ◽  
Vol 68 (7) ◽  
pp. 1337-1339 ◽  
Author(s):  
Shih-Chieh Chuang ◽  
Che-Chen Lin ◽  
Cheng-Yuan Peng ◽  
Wen-Hsin Huang ◽  
Wen-Pang Su ◽  
...  
Keyword(s):  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Control Study

scholarly journals Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study

PLoS Medicine ◽  
2014 ◽  
Vol 11 (9) ◽  
pp. e1001736 ◽  
Author(s):  
Jonathan Zipursky ◽  
Erin M. Macdonald ◽  
Simon Hollands ◽  
Tara Gomes ◽  
Muhammad M. Mamdani ◽  
...  
Keyword(s):  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Control Study

scholarly journals Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study

2018 ◽  
Vol 285 (2) ◽  
pp. 205-214 ◽  
Author(s):  
A. Tran-Duy ◽  
N. J. Connell ◽  
F. H. Vanmolkot ◽  
P. C. Souverein ◽  
N. J. de Wit ◽  
...  
Keyword(s):  
Iron Deficiency ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Control Study

scholarly journals Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study

2010 ◽  
Vol 22 (3) ◽  
pp. 903-910 ◽  
Author(s):  
S. Pouwels ◽  
A. Lalmohamed ◽  
P. Souverein ◽  
C. Cooper ◽  
B. J. Veldt ◽  
...  
Keyword(s):  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Case Control Study ◽  
Femur Fracture ◽  
Population Based ◽  
Case Control ◽  
Control Study

Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study

2010 ◽  
Vol 19 (11) ◽  
pp. 1131-1136 ◽  
Author(s):  
Hui-Fen Chiu ◽  
Ya-Wen Huang ◽  
Chih-Ching Chang ◽  
Chun-Yuh Yang
Keyword(s):  
Hip Fracture ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Control Study

scholarly journals Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study

2010 ◽  
Vol 19 (8) ◽  
pp. 792-802 ◽  
Author(s):  
Sascha Dublin ◽  
Rod L. Walker ◽  
Michael L. Jackson ◽  
Jennifer C. Nelson ◽  
Noel S. Weiss ◽  
...  
Keyword(s):  
Older Adults ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
H2 Blockers ◽  
Control Study

scholarly journals Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study

Drug Safety ◽  
2015 ◽  
Vol 38 (12) ◽  
pp. 1187-1199 ◽  
Author(s):  
Alejandro Arana ◽  
Catherine B. Johannes ◽  
Lisa J. McQuay ◽  
Cristina Varas-Lorenzo ◽  
Daniel Fife ◽  
...  
Keyword(s):  
Sudden Cardiac Death ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Cardiac Death ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Nested Case Control ◽  
Control Study

Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population–based case–control study

2019 ◽  
Vol 59 ◽  
pp. 65-69 ◽  
Author(s):  
Henrik Falhammar ◽  
Jonatan D. Lindh ◽  
Jan Calissendorff ◽  
Jakob Skov ◽  
David Nathanson ◽  
...  
Keyword(s):  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Control Study

scholarly journals Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case–control study

BMJ Open ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. e041543
Author(s):  
Keiko Ikuta ◽  
Shunsaku Nakagawa ◽  
Kenji Momo ◽  
Atsushi Yonezawa ◽  
Kotaro Itohara ◽  
...  
Keyword(s):  
Acute Kidney Injury ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Case Control Study ◽  
Kidney Injury ◽  
Case Control ◽  
Renal Diseases ◽  
Increased Risk ◽  
Nested Case Control ◽  
Control Study

ObjectivesThis study aimed to assess whether the combined use of proton pump inhibitors (PPIs) with non-steroidal anti-inflammatory drugs (NSAIDs) or antibiotics (penicillins, macrolides, cephalosporins or fluoroquinolones) was associated with an increased risk of acute kidney injury (AKI).DesignA nested case–control study.SettingA health insurance claims database constructed by the Japan Medical Data Center.ParticipantsPatients were eligible if they were prescribed a PPI, NSAID and antibiotic at least once between January 2005 and June 2017. The patients who were new PPI users and did not have any history of renal diseases before cohort entry were included (n=219 082). The mean age was 45 and 44% were women.InterventionsCurrent use of PPIs, NSAIDs, or antibiotics.Primary outcome measuresAcute kidney injury.ResultsDuring a mean follow-up of 2.4 (SD, 1.7) years, 317 cases of AKI were identified (incidence rate of 6.1/10 000 person-years). The current use of PPIs was associated with a higher risk of AKI compared with past PPI use (unadjusted OR, 4.09; 95% CI, 3.09 to 5.44). The unadjusted ORs of AKI for the current use of PPIs with NSAIDs, cephalosporins and fluoroquinolones, compared with the current use of PPIs alone, were 3.92 (95% CI, 2.40 to 6.52), 2.57 (1.43 to 4.62) and 3.08 (1.50 to 6.38), respectively. The effects of concurrent use of PPIs with NSAIDs, cephalosporins or fluoroquinolones remain significant in the adjusted model. The analyses on absolute risk of AKI confirmed the results from the nested case–control study.ConclusionsConcomitant use of NSAIDs with PPIs significantly increased the risk for AKI. Moreover, the results suggested that concomitant use of cephalosporins or fluoroquinolones with PPIs was associated with increased risk of incident AKI.

Sign in / Sign up

Export Citation Format

Share Document